Researchers continue to excited about the medication , a innovative dual compound showing promising outcomes in early trials for weight loss . It acts by targeting several pathways : GLP-1 and GIP, that https://aoifeutyn136339.diowebhost.com/95959787/this-new-hope-for-size-reduction